Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults With Cervical Dystonia: Results From the Open-label Extension of a Phase 2 Trial

被引：0
|
作者：
Jankovic, Joseph [1 ]
Oh, Chad [2 ]
Liu, Yan [2 ]
Abdul-Musawir, Najeebah [2 ]
Comella, Cynthia [3 ]
机构：
[1] Baylor Coll Med, St Lukes Med Ctr, Dept Neurol, Parkinsons Dis Ctr & Movement Disorders Clin, McNair Campus,7200 Cambridge St,Suite 9A, Houston, TX USA
[2] AEON Biopharma Inc, Irvine, CA USA
[3] Rush Univ, Med Ctr, Chicago, IL USA
来源：
TOXICON | 2024年 / 237卷
关键词：
Cervical dystonia; Type A botulinum toxins; PrabotulinumtoxinA; Torticollis; Dyskinesias; Neurologic manifestations;
D O I：
10.1016/j.toxicon.2024.107415
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：36 / 37
页数：3
相关论文
共 50 条
  • [21] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [22] IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
    Marciniak, Christina
    Munin, Michael C.
    Brashear, Allison
    Rubin, Bruce S.
    Patel, Atul T.
    Slawek, Jaroslaw
    Hanschmann, Angelika
    Hiersemenzel, Reinhard
    Elovic, Elie P.
    ADVANCES IN THERAPY, 2019, 36 (01) : 187 - 199
  • [23] Long-Term Safety and Efficacy of Voxelotor for Patients with Sickle Cell Disease: Results from an Open-Label Extension of the Phase 3 HOPE Trial
    Achebe, Maureen
    Hassab, Hoda
    Alkindi, Salam
    Brown, R. Clark Clark
    Telfer, Paul
    Biemond, Bart J.
    Gordeuk, Victor R.
    Lipato, Thokozeni
    Tonda, Margaret
    Gray, Sarah
    Howard, Joanna
    BLOOD, 2021, 138
  • [24] Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension
    Nowak, Richard J.
    Breiner, Ari
    Bril, Vera
    Allen, Jeffrey A.
    Khan, Shaida
    Levine, Todd
    Jacobs, Daniel H.
    Sahagian, Gregory
    Siddiqi, Zaeem A.
    Xu, Jing
    Macias, William L.
    Benatar, Michael
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (01): : 194 - 206
  • [25] Efficacy and safety of switching from dupilumab to upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension trial
    Blauvelt, A.
    Ladizinski, B.
    Prajapati, V. H.
    Laquer, V.
    Fischer, A.
    Eisman, S.
    Wu, T.
    Vigna, N.
    Teixeira, H. D.
    Liu, J.
    Eyerich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E142 - E142
  • [26] LONG-TERM SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH UNCONTROLLED POS: RESULTS FROM A PHASE III OPEN-LABEL EXTENSION TRIAL
    Husain, A.
    Faught, E.
    Chung, S.
    Isojarvi, J.
    McShea, C.
    Doty, P.
    EPILEPSIA, 2011, 52 : 155 - 155
  • [27] Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
    Papp, Kim A.
    de Vente, Saskia
    Zeng, Jiewei
    Flack, Mary
    Padilla, Byron
    Tyring, Stephen K.
    DERMATOLOGY AND THERAPY, 2021, 11 (02) : 487 - 497
  • [28] Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
    Kim A. Papp
    Saskia de Vente
    Jiewei Zeng
    Mary Flack
    Byron Padilla
    Stephen K. Tyring
    Dermatology and Therapy, 2021, 11 : 487 - 497
  • [29] Efficacy and safety of lurasidone in adolescents with schizophrenia: Results of a 2-year, open-label extension study
    Goldman, R.
    Correll, C.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S89
  • [30] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIAL
    Khanna, D.
    Lin, C. J. F.
    Spotswood, H.
    Siegel, J.
    Furst, D.
    Denton, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 390 - 390
12345